Ocuphire Pharma: Entry Into A Material Definitive Agreement, Completion Of Acquisition Or Disposition Of Assets, Results Of Operations And Financial Condition, Unregistered Sales Of Equity Securities, Material Modification To The Rights Of Security Holders, Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Regulation Fd Disclosure, Financial Statements And Exhibits

Show full article

This functionality is available for registred users only

• Full name
  Opus Genetics, Inc.
• Registration country
  USA
• Industry
  Pharmaceutical Preparation and Biotechnology
• М/S&P/F
  *** / *** / ***